LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of TAB008 and bevacizumab in healthy volunteers.

Photo by cravethebenefits from unsplash

e14504Background: This study compared the pharmacokinetic (PK) profiles of the biosimilar TAB008 with bevacizumab (EU) in healthy adult males. Methods: A randomized, double-blind, single-dose study... Click to show full abstract

e14504Background: This study compared the pharmacokinetic (PK) profiles of the biosimilar TAB008 with bevacizumab (EU) in healthy adult males. Methods: A randomized, double-blind, single-dose study...

Keywords: bevacizumab healthy; study; tab008 bevacizumab; single dose; dose study

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.